Eris buys 70% stake in Swiss Parenterals
India Business News: NEW DELHI: Eris LifeSciences is acquiring a 51% stake in Swiss Parenterals, a sterile injectable manufacturer, for Rs 637.
Stay updated with breaking news from Sterile Injectable. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
India Business News: NEW DELHI: Eris LifeSciences is acquiring a 51% stake in Swiss Parenterals, a sterile injectable manufacturer, for Rs 637.
Forward and Onward for SustainABLE Lives ...
/PRNewswire/ -- The "Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2024-2034" report has been added to...
The market suffered a small correction this week but the underlying trend remains bullish. We expect a short rally next week before a deeper decline.
Caplin Point Laboratories Ltd has announced that the USFDA had completed its GMP and PAI inspection of Caplin Steriles Limited's Sterile Injectable site at Gummidipoondi.